Photodynamic therapy (PDT) for lung cancers

Journal of Thoracic Oncology

Volumn 1, Issue 5, 2006, Pages 489-493

  Usuda, Jitsuo ^a   Kato, Harubumi ^a   Okunaka, Tetsuya ^b   Furukawa, Kinya ^a   Tsutsui, Hidemitsu ^a   Yamada, Kimito ^a   Suga, Yasuhiro ^a   Honda, Hidetoshi ^a   Nagatsuka, Yoshitaka ^a   Ohira, Tatsuo ^a   Tsuboi, Masahiro ^a   Hirano, Takashi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Lung cancer; Photodynamic therapy

Indexed keywords

MATRIX METALLOPROTEINASE INHIBITOR; PHOTOFRIN; PHOTOSENSITIZING AGENT; TALAPORFIN; VASCULOTROPIN INHIBITOR;

ADVANCED CANCER; AIRWAY OBSTRUCTION; ANTINEOPLASTIC ACTIVITY; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER THERAPY; CELL DEATH; CLINICAL TRIAL; DIODE LASER; DISEASE SEVERITY; EARLY CANCER; ESOPHAGUS CANCER; HUMAN; LASER; LOW LEVEL LASER THERAPY; LUNG CANCER; LUNG FUNCTION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; LUNG TUMOR; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY;

COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 34247231567     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200606000-00018     Document Type: Review

References (43)

1. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-902.
2. Oleinick NL, Morris RL Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 2002;1:1-22.
3. Weishaupt KR, Gomer CJ Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976;36:2326-2329.
4. Moan J Berg K. The photodegradation of porphyrins in cell can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 1991;53:54-553.
5. Gomer CJ. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol. 1991;54:1093-1107.
6. Xue LY, He J and Oleinick NL. Rapid tyrosine phosphorylation of HS1 in the response of mouse lymphoma L5178Y-R cells to photodynamic treatment sensitized by phthalocyanine Pc 4. Photochem Photobiol 1997;66:105-113.
7. Usuda J, Okunaka T, Furukawa K, et al. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis. Int J Cancer 2001;93:475-480.
8. Henderson BW Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-157.
9. Finger VH, Wieman TJ, Wiehle SA, et al. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res 1992;52:4914-4921.
10. Kato H, Konaka C, Ono J, et al. Cancer localization by detection of fluorescence by means of HpD administration and krypton ion laser photoradiation in canine lung cancer. Lung Cancer 1981;21:439-445.
11. Hayata Y, Kato H, Konaka C, et al. Fiberoptic bronchoscopic photoradiation in experimentally induced canine lung cancer. Cancer 1983;51:50-56.
12. Kato H, Aizawa K, Ono J, et al. Clinical measurement of tumor fluorescence using a new diagnostic system with hematoporphyrin derivative, laser photoradiation, and a spectroscope. Lasers Surg Med 1984;4:49-58.
13. Hayata Y, Kato H, Konaka C, et al. Hematoporphyrin derivative and laser photoradiation in the treatment of the lung cancer. Chest 1982;81:269-277.
14. Kato H, Konaka C, Kawate N, et al. Five-year disease-free survival of a lung cancer patient treated only by photodynamic therapy. Chest 1986;90:768-770.
15. Furuse K, Fukuoka M, Kato H, et al. A prospective phase II study on photodynamic therapy with Photofrin II for centrally located early-stage lung cancer. J Clin Oncol 1993;11:1852-1857.
16. Kato H, Usuda J, Okunaka T, et al. The history of the study of photodynamic therapy and photodynamic diagnosis in the Department of Surgery, Tokyo Medical University. Photodiagn Photodyn Ther 2004;1:107-110.
17. Furukawa K, Okunaka T, Tsuchida T, et al. A phase I clinical study of photodynamic therapy for early stage lung carcinoma using ME2906 and a diode laser system. Porphyrins 1998;7:199-206.
18. Kato H, Furukawa K, Sato M, et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorine e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 2003;42:103-111.
19. Cortese DA, Edell ES and Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997;72:595-602.
20. Kato H. Study on photodynamic therapy by laser. Annual Report of the Cancer Research Ministry of Health and Welfare. Tokyo: National Cancer Center, 1988. Pp. 255-261 [in Japanese].
21. Gomer CJ. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol 1991;54:1093-1107.
22. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993;85:443-456.
23. Usuda K, Saito Y, Nagamoto N, et al. Relation between bronchoscopic findings and tumor size of roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Surg 1993;106:1098-1103.
24. Furukawa K, Kato H, Konaka C, et al. Locally recurrent type early-stage lung cancer less than 1.0 cm in diameter after complete remission by photodynamic therapy. Chest 2006;128:3269-3275.
25. Tsuboi M, Hayashi A, Ikeda N, et al. Optical coherence tomography in the diagnosis of bronchial lesions. Lung Cancer 2006;49:387-394.
26. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low dose spiral CT versus radiography. Radiology 1996;201:798-802.
27. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
28. Okunaka T, Kato H, Tsutsui H, et al. Photodynamic therapy for peripheral lung cancer. Lung Cancer 2004;43:77-82.
29. Nguyen CL, Scott WJ, Young NA, et al. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest 2006;128:3507-3511.
30. Furukawa K, Kato Y, Shimatani H, et al. Percutaneous microwave coagulation therapy for lung cancers. J Microwave Surg 2001;19:55-59.
31. Diaz-Jimenez JP, Martinez-Ballarin JE, Llunell A, et al. Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction. Eur Respir J 1999;14:800-805.
32. Vincet RG, Dougherty TJ, Rao U, et al. Photoradiation therapy in advanced carcinoma of the trachea and bronchus. Chest 1984;85:29.-
33. McCaughan JrJS Hawley PC, Walker J. Management of endo-bronchial tumors: a comparative study. Semin Surg Oncol 1989;5:38.-
34. LoCicero J, Metzdorff M, Almgren C. Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. Chest 1990;98:97.-
35. Delaney TF, Sindelar WF, Tochner Z, et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys 1993;25:445.-
36. Furukawa K, Okunaka T, Yamamoto H, et al. Effectiveness of photodynamic therapy and Nd-YAG laser treatment for obstructed tracheobronchial malignancies. Diagn Ther Endosc 1999;5:161-166.
37. Kato H, Konaka C, Ono J. Preoperative laser photodynamic therapy in combination with operation in the lung cancer. J Thorac Cardiovasc Surg 1985;90:420-429.
38. Okunaka T, Kato H, Konaka C, et al. Photodynamic therapy for multiple primary bronchogenic carcinoma. Cancer 1991;68:253-258.
39. Okunaka T, Hiyoshi T, Furukawa K, et al. Lung cancer treated with photodynamic therapy and surgery. Diagn Ther Endosc 1999;5:155-160.
40. Ferrario A von Tiehl K, Rucker N, et al. Anti-angiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 2000;60:4066-4069.
41. Ferrario A von Tiehl K, Wong S, et al. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res 2002;62:3956-3961.
42. Gollnick SO, Evans SS, Baumann H, et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 2003;88:1772-1779.
43. Ferrario A, Chantrain C von Tiel K, et al. The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res 2004;64:2328-2332.